Potassium canrenoate structure
|
Common Name | Potassium canrenoate | ||
|---|---|---|---|---|
| CAS Number | 2181-04-6 | Molecular Weight | 396.56200 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C22H29KO4 | Melting Point | N/A | |
| MSDS | Chinese USA | Flash Point | N/A | |
| Symbol |
GHS07 |
Signal Word | Warning | |
Use of Potassium canrenoateCanrenoate (Aldadiene) potassium, a prodrug that releases canrenone, is a potent, competitive mineralocorticoid receptor (aldosterone receptor) antagonist. Potassium canrenoate, as a diuretic, is used for the research of hypertension[1][2][3]. |
| Name | Canrenoic Acid Potassium Salt |
|---|---|
| Synonym | More Synonyms |
| Description | Canrenoate (Aldadiene) potassium, a prodrug that releases canrenone, is a potent, competitive mineralocorticoid receptor (aldosterone receptor) antagonist. Potassium canrenoate, as a diuretic, is used for the research of hypertension[1][2][3]. |
|---|---|
| Related Catalog | |
| In Vivo | Potassium canrenoate has been shown to cause in rats a dose-dependent increase in myelogenous leukemia and statistically significant increases in malignant tumor of the liver, thyroid, brain and mammary gland[2][3]. Potassium canrenoate (20 mg/kg/day; drinking water) reduces isoprenaline-induced cardiac fibrosis in the rat[4]. |
| References |
| Molecular Formula | C22H29KO4 |
|---|---|
| Molecular Weight | 396.56200 |
| Exact Mass | 396.17000 |
| PSA | 77.43000 |
| LogP | 2.55550 |
| Storage condition | 2-8°C |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
MUTATION DATA
|
| Symbol |
GHS07 |
|---|---|
| Signal Word | Warning |
| Hazard Statements | H302 |
| Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Gloves |
| Hazard Codes | Xn: Harmful; |
| Risk Phrases | R22 |
| Safety Phrases | S36 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | 3 |
| RTECS | TU3500000 |
| HS Code | 2916209090 |
| HS Code | 2916209090 |
|---|---|
| Summary | 2916209090 other cyclanic, cyclenic or cyclotherpenic monocarboxylic acids, their anhydrides, halides, peroxides, peroxyacids and their derivatives VAT:17.0% Tax rebate rate:9.0% Supervision conditions:AB(certificate of inspection for goods inward,certificate of inspection for goods outward) MFN tariff:6.5% General tariff:30.0% |
|
Effect of the steroid K-canrenoate on hsp70 expression and tissue damage in transgenic Drosophila melanogaster (hsp70-lacZ) Bg9.
J. Insect Sci. 12 , 92, (2012) In the present study the effect of 0.1, 0.2, 0.4, 0.8, and 1.0 µL/mL of the steroid K-canrenoate was evaluated in the third instar larvae of transgenic Drosophila melanogaster (hsp70-lacZ) Bg(9) for 6... |
|
|
Mineralocorticoids participate in the reduced vascular reactivity of pregnant rats.
Am. J. Physiol. Heart Circ. Physiol. 302(5) , H1195-201, (2012) The renin-angiotensin-aldosterone (RAA) system is markedly activated in pregnancy. We evaluated if mineralocorticoid receptors (MR), a major component of the RAA system, are involved in the reduced va... |
|
|
Akt-mediated cardioprotective effects of aldosterone in type 2 diabetic mice.
FASEB J. 28(6) , 2430-40, (2014) Studies have shown that aldosterone would have angiogenic effects and therefore would be beneficial in the context of cardiovascular diseases. We thus investigated the potential involvement of aldoste... |
| Potassium canrenoate |
| Canrenoic acid potassium salt |
| 17-Hydroxy-3-oxopregna-4,6-diene-21-carboxylic acid,Potassium canrenoate |
| MFCD05662375 |
| EINECS 218-554-9 |